Royalty Report: Medical, Device, Surgical – Collection: 27403

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 9

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 9

Primary Industries

  • Medical
  • Device
  • Surgical
  • Therapeutic
  • Stent
  • cardiac
  • Technical Know How
  • Supply
  • Catheter
  • Coating

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 27403

License Grant
The Company owns exclusive, worldwide, perpetual licenses to develop, manufacture and market its Flo-Rester products from an undisclosed Licensor.
License Property
Flo-Rester products are vessel occluders manufactured from medical grade silicone.  The Flo-Rester products are designed to interrupt blood flow in arteries and to stent (hold open) them during surgery, thereby facilitating the suturing together of vessels.  Flo-Rester consists of a flexible shaft with small bulbs at each end that are inserted into the blood vessel at the point where the artery bypass is sutured to the artery to stop the blood flow.

IPSCIO Record ID: 27347

License Grant
The Company entered into an agreement with an undisclosed Licensor for card-vascular products.
License Property
Bio-Vascular Probe is a flexible shaft with varying sizes of bulbous tips on either end.  Biograft is used to bypass occluded blood vessels and is produced from modified human umbilical veins.
Field of Use
Surgeons use the Bio-Vascular Probe to locate occlusions or blockages in arteries and to ascertain the blood flow characteristics of arteries.

IPSCIO Record ID: 372642

License Grant
Licensor, a nonprofit academic medical center, hereby grants to Licensee for the Term an exclusive, worldwide license to use the Licensed Technology in the Field of Use to (i) make, have made, develop, use, import, export, distribute, market, promote, offer for sale, and sell Products in the Field of Use, and (ii) practice in the Field of Use any method, process or procedure claimed within the Licensed Technology.
License Property
Licensed Patents
– U.S. Utility Application No.11/700,987, Filed 2/1/2007, “A METHOD AND APPARATUS FOR INCREASING BLOOD FLOW THROUGH AN OBSTRUCTED BLOOD VESSEL”, Henry Woo, MD, David Fiorella, MD, PhD. Publication Number US 20070208361 A1.

– U.S. Application No.60/764,206, Filed 2/1/2006, “A METHOD AND APPARATUS FOR INCREASING BLOOD FLOW THROUGH AN OBSTRUCTED BLOOD VESSEL”, Henry Woo, MD, David Fiorella, MD, PhD. Expired.

-U.S. Application No.60/793,588, Filed 4/20/2006, “A METHOD AND APPARATUS FOR INCREASING BLOOD FLOW THROUGH AN OBSTRUCTED BLOOD VESSEL”, Henry Woo, MD, David Fiorella, MD, PhD. Expired.

Field of Use
The license relates to its revascularization technology for the treatment of ischemic stroke.

Ischemic stroke occurs when a blood clot blocks or narrows an artery leading to the brain. A blood clot often forms in arteries damaged by the buildup of plaques (atherosclerosis). It can occur in the carotid artery of the neck as well as other arteries. This is the most common type of stroke.

IPSCIO Record ID: 289220

License Grant
Licensor grants, under Licensor’s and each of its Affiliates’ respective rights in the Licensed Patents, a non-exclusive, non-transferable, worldwide, irrevocable, perpetual license to make, have made, use, import, export, market, sell, have sold, offer for sale, distribute and otherwise exploit Royalty-Bearing Products within the Orthopedic Field.

The Parties agree to promptly dismiss all claims and counter-claims with this agreement.

License Property
Royalty-Bearing Products means the Accused Products, the Non-Accused Products and any New Product or Other Product that Licensee elects to be a Royalty-Bearing Product; each of the foregoing solely to the extent the manufacture, use, sale, offering for sale, importation, exportation or other exploitation of which in a particular country would, in the absence of the licenses, covenants, releases and immunities granted by Licensor under this Agreement, infringe, contribute to the infringement of, or induce the infringement of any Valid Claim of any patent within the Licensed Patents issued in such country.

The accused products are Magnum I, Magnum II, and, Mini-Magnum.

The patents relate to Suture anchor, Bone suture, Body tissue fastening, Method of positioning body tissue relative to a bone, and, Method and apparatus for use in anchoring a suture.

Field of Use
Orthopedic Field means the branch of medicine that deals with the diagnosis, analysis, treatment, prevention, correction, rehabilitation or study of injuries or disorders of the skeletal system and associated muscles, joints and ligaments.

IPSCIO Record ID: 133630

License Grant
The Company purchased certain assets associated with the manufacture and sale of the arterial blood gas products (the 'ABG Assets') and the Company then leased the ABG Assets back to Licensee in exchange for a royalty of the net arterial blood gas product line sales.
License Property
ABG Assets are the arterial blood gas products which are used for specialty cardiopulmonary support, respiratory and anesthesia disposable devices.
Field of Use
This agreement pertains to the medical industry.

IPSCIO Record ID: 27346

License Grant
Biograft peripheral vascular graft; Biograft is used to bypass occluded blood vessels and is produced from modified human umbilical veins; for use in lower limb vascular reconstructions when a saphenous vein is not available.

IPSCIO Record ID: 195625

License Grant
Licensor, an individual, hereby agrees to assign to the Company all of his right, title and interest to the inventions (the 'Inventions') and related patent rights.
License Property
The Inventions shall consist of the inventions described in 'Daisy Occluder and Method for Septal Defect Repair' (U.S. Patent Application filed on August 28, 1996, App. No. 08/697,837).
Field of Use
08/697,837 (5,741,297) The present invention relates to an occluder structure and method for the repair of intracardiac and vascular septal defects, as well as other abnormal openings in tissue planes such as the abdominal wall.

A septum, which is a thin wall of muscle or tissue which divides two or more chambers of the heart or other anatomic spaces of the human body, sometimes is perforated by an abnormal aperture passing through the septum, described as a septal defect. When septal defects occur between adjacent chambers of the heart or its associated major blood vessels, blood can leak from one chamber or artery to another imposing added strain on the heart which may lead to heart failure. An opening in the abdominal wall may allow bowel to pass through it, causing a hernia.

The surgical repair of intracardiac defects has required the use of open chest surgical techniques wherein the defect is directly sutured shut.

IPSCIO Record ID: 299236

License Grant
Under the initial agreement, the Canadian Licensor agreed to license on a co-exclusive certain patent rights, license rights, and technology.

This agreement is extending Licensee’s worldwide right and license to use, manufacture, have manufactured, distribute and sell, and to grant sublicenses to its Affiliates to use, manufacture, have manufactured, distribute and sell, the Licensor Technology in the Peripheral Vascular Field of Use and the GI Field of Use.

Licensor newly grants its licensee, the right for Licensee to have third party Distributors distribute Eligible Peripheral Vascular and/or GI Products.

This agreement is co-exclusive with an option to become exclusive.

License Property
This agreement is for paclitaxel or certain other agents as a coating for certain medical devices.

The license agreement regards paclitaxel-eluting stent products and related technologies.  Paclitaxel is released from the balloon or stent to prevent scar tissue formation in the blood vessel that can re-obstruct the artery (restenosis).

Field of Use
As used herein, the Coronary Vascular Field of Use means endoluminal vascular Licensed Applications for the treatment and/or prevention of disease of the coronary arteries and their branches, or other vasculature providing blood flow to the heart.

As used herein, the Peripheral Vascular Field of Use means the endoluminal vascular licensed applications for the treatment or preventionof disease of the peripheral blood vessels of the body.  Notwithstanding the foregoing, Peripheral Vascular Field of Use excludes any application in the Coronary Vascular Field of Use.  

GI Field of Use means the endoluminal licensed applications for the treatment or prevention of disease of the alimentary tract or liver.

IPSCIO Record ID: 27406

License Grant
The Company, in its acquisition of technology in 1993 related to its TMR therapy from the University.  Under this agreement, the Company has a worldwide exclusive license to any patents that issue in connection related with cardiac revascularization technology for the treatment of advanced cardiovascular disease and severe angina pain through transmyocardial revascularization, TMR.
License Property
TMR is a treatment aimed at improving blood flow to areas of the heart that were not treated by angioplasty or surgery. A special carbon dioxide (CO2) laser is used to create small channels in the heart muscle, improving blood flow in the heart. TMR is a surgical procedure. The procedure is performed through a small left chest incision or through a midline incision. Frequently, it is performed with coronary artery bypass surgery, but occasionally it is performed independently.
Field of Use
Field of use  Medical Industry primarily used by a heart surgeon.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.